These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34344393)

  • 1. Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation.
    Munro S; Wahl K; Soon JA; Guilbert E; Wilcox ES; Leduc-Robert G; Ansari N; Devane C; Norman WV
    Implement Sci; 2021 Aug; 16(1):76. PubMed ID: 34344393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists.
    Zusman EZ; Munro S; Norman WV; Soon JA
    BMJ Open; 2022 Oct; 12(10):e063370. PubMed ID: 36207038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol.
    Norman WV; Munro S; Brooks M; Devane C; Guilbert E; Renner R; Kendall T; Soon JA; Waddington A; Wagner MS; Dunn S
    BMJ Open; 2019 Apr; 9(4):e028443. PubMed ID: 31005943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and Facilitators to the Implementation of First Trimester Medical Abortion With Mifepristone in the Province of Québec: A Qualitative Investigation.
    Wagner MS; Munro S; Wilcox ES; Devane C; Norman WV; Dunn S; Soon JA; Guilbert É
    J Obstet Gynaecol Can; 2020 May; 42(5):576-582. PubMed ID: 31924442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers.
    Devane C; Renner RM; Munro S; Guilbert É; Dunn S; Wagner MS; Norman WV
    Pilot Feasibility Stud; 2019; 5():126. PubMed ID: 31720004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' experiences dispensing misoprostol and readiness to dispense mifepristone.
    Ferketa M; Moore A; Klein-Barton J; Stulberg D; Hasselbacher L
    J Am Pharm Assoc (2003); 2024; 64(1):245-252.e1. PubMed ID: 37913990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives Among Canadian Physicians on Factors Influencing Implementation of Mifepristone Medical Abortion: A National Qualitative Study.
    Munro S; Guilbert E; Wagner MS; Wilcox ES; Devane C; Dunn S; Brooks M; Soon JA; Mills M; Leduc-Robert G; Wahl K; Zannier E; Norman WV
    Ann Fam Med; 2020 Sep; 18(5):413-421. PubMed ID: 32928757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation.
    Guilbert E; Wagner MS; Munro S; Wilcox ES; Dunn S; Soon JA; Devane C; Norman WV
    Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):190-198. PubMed ID: 32312130
    [No Abstract]   [Full Text] [Related]  

  • 9. "No Big Deal": A Qualitative Study of Pharmacists' Perspectives on Dispensing Mifepristone for Medication Abortion.
    Kaller S; Ma M; Gurazada T; Baba CF; Rafie S; Raine-Bennett T; Averbach S; Chen M; Berry E; Meckstroth KR; Grossman D
    Womens Health Issues; 2022; 32(6):571-577. PubMed ID: 35918240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients.
    Vogel KI; LaRoche KJ; El-Haddad J; Chaumont A; Foster AM
    Contraception; 2016 Aug; 94(2):137-42. PubMed ID: 27125893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispensing mifepristone for medical abortion in Canada: Pharmacists' experiences of the first year.
    Zusman EZ; Munro S; Norman WV; Soon JA
    Can Pharm J (Ott); 2023; 156(4):204-214. PubMed ID: 37435503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion.
    Kaller S; Morris N; Biggs MA; Baba CF; Rafie S; Raine-Bennett TR; Creinin MD; Berry E; Micks EA; Meckstroth KR; Averbach S; Grossman D
    J Am Pharm Assoc (2003); 2021; 61(6):785-794.e1. PubMed ID: 34281806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study.
    Dunn S; Munro S; Devane C; Guilbert E; Jeong D; Stroulia E; Soon JA; Norman WV
    J Med Internet Res; 2022 May; 24(5):e34302. PubMed ID: 35511226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia.
    LaRoche KJ; Wynn LL; Foster AM
    Contraception; 2020 Apr; 101(4):256-260. PubMed ID: 31927029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research.
    Clark WH; Gold M; Grossman D; Winikoff B
    Contraception; 2007 Apr; 75(4):245-50. PubMed ID: 17362700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical termination of pregnancy in general practice in Australia: a descriptive-interpretive qualitative study.
    Dawson AJ; Nicolls R; Bateson D; Doab A; Estoesta J; Brassil A; Sullivan EA
    Reprod Health; 2017 Mar; 14(1):39. PubMed ID: 28288649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I just was really scared, because it's already such an uncertain time": Exploring women's abortion experiences during the COVID-19 pandemic in Canada.
    Hukku S; Ménard A; Kemzang J; Hastings E; Foster AM
    Contraception; 2022 Jun; 110():48-55. PubMed ID: 35123980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
    LaRoche KJ; Wylie A; Persaud M; Foster AM
    Contraception; 2022 May; 109():37-42. PubMed ID: 35031301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
    Petitet PH; Ith L; Cockroft M; Delvaux T
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leadership for success in transforming medical abortion policy in Canada.
    Dineley B; Munro S; Norman WV
    PLoS One; 2020; 15(1):e0227216. PubMed ID: 31914156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.